Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20805256rdf:typepubmed:Citationlld:pubmed
pubmed-article:20805256lifeskim:mentionsumls-concept:C0025118lld:lifeskim
pubmed-article:20805256lifeskim:mentionsumls-concept:C0035647lld:lifeskim
pubmed-article:20805256lifeskim:mentionsumls-concept:C0003289lld:lifeskim
pubmed-article:20805256lifeskim:mentionsumls-concept:C0011847lld:lifeskim
pubmed-article:20805256lifeskim:mentionsumls-concept:C0543472lld:lifeskim
pubmed-article:20805256lifeskim:mentionsumls-concept:C0679717lld:lifeskim
pubmed-article:20805256lifeskim:mentionsumls-concept:C1659987lld:lifeskim
pubmed-article:20805256pubmed:issue12lld:pubmed
pubmed-article:20805256pubmed:dateCreated2010-11-30lld:pubmed
pubmed-article:20805256pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20805256pubmed:abstractTextTo assess the association between antidepressant medicine use and risk of developing diabetes during the Diabetes Prevention Program (DPP) and Diabetes Prevention Program Outcomes Study (DPPOS).lld:pubmed
pubmed-article:20805256pubmed:languageenglld:pubmed
pubmed-article:20805256pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20805256pubmed:citationSubsetIMlld:pubmed
pubmed-article:20805256pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20805256pubmed:statusMEDLINElld:pubmed
pubmed-article:20805256pubmed:monthDeclld:pubmed
pubmed-article:20805256pubmed:issn1935-5548lld:pubmed
pubmed-article:20805256pubmed:authorpubmed-author:Diabetes...lld:pubmed
pubmed-article:20805256pubmed:authorpubmed-author:Barrett-Conno...lld:pubmed
pubmed-article:20805256pubmed:authorpubmed-author:KnowlerWillia...lld:pubmed
pubmed-article:20805256pubmed:authorpubmed-author:MaYongYlld:pubmed
pubmed-article:20805256pubmed:authorpubmed-author:RubinRichard...lld:pubmed
pubmed-article:20805256pubmed:authorpubmed-author:MarreroDavid...lld:pubmed
pubmed-article:20805256pubmed:authorpubmed-author:PeyrotMarkMlld:pubmed
pubmed-article:20805256pubmed:authorpubmed-author:PriceDavid...lld:pubmed
pubmed-article:20805256pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20805256pubmed:volume33lld:pubmed
pubmed-article:20805256pubmed:ownerNLMlld:pubmed
pubmed-article:20805256pubmed:authorsCompleteYlld:pubmed
pubmed-article:20805256pubmed:pagination2549-51lld:pubmed
pubmed-article:20805256pubmed:meshHeadingpubmed-meshheading:20805256...lld:pubmed
pubmed-article:20805256pubmed:meshHeadingpubmed-meshheading:20805256...lld:pubmed
pubmed-article:20805256pubmed:meshHeadingpubmed-meshheading:20805256...lld:pubmed
pubmed-article:20805256pubmed:meshHeadingpubmed-meshheading:20805256...lld:pubmed
pubmed-article:20805256pubmed:year2010lld:pubmed
pubmed-article:20805256pubmed:articleTitleAntidepressant medicine use and risk of developing diabetes during the diabetes prevention program and diabetes prevention program outcomes study.lld:pubmed
pubmed-article:20805256pubmed:affiliationDepartment of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. dppmail@biostat.bsc.gwu.edulld:pubmed
pubmed-article:20805256pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20805256pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:20805256pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:20805256pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:20805256pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
pubmed-article:20805256pubmed:publicationTypeResearch Support, N.I.H., Intramurallld:pubmed